A prospective study of gemcitabine and carboplatin as first-line therapy in advanced non-small cell lung cancer: Toxicity of a three- versus a four-week schedule

Seminars in Oncology

Volumn 28, Issue , 2001, Pages 10-14

  Parente, Bárbara ^a   Barroso, Ana ^a   Conde, Sara ^a   Guimarães, Tânia ^a   Seada, Jorge ^a  

^a CENTRO HOSPITALAR DE VILA NOVA DE GAIA ESPINHO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; GEMCITABINE;

ADULT; ADVANCED CANCER; AGED; ANEMIA; AREA UNDER THE CURVE; ASTHENIA; BONE MARROW TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CLINICAL TRIAL; DOSE CALCULATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MALE; METASTASIS; NAUSEA; NEUTROPENIA; PATIENT SCHEDULING; PRIORITY JOURNAL; REVIEW; SURVIVAL TIME; THROMBOCYTOPENIA; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; DEOXYCYTIDINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0034880789     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0093-7754(01)80003-8     Document Type: Article

References (18)

1. New combinations in the treatment of lung cancer: A time for optimism
2. Integration of new agents into the treatment of advanced non-small cell lung cancer
3. Gemcitabine: Single-agent and combination therapy in non-small cell lung cancer
4. Single-agent gemcitabine: An active and better tolerated alternative to standard cisplatin-based chemotherapy in locally advanced or metastatic non-small cell lung cancer
5. Combined cisplatin and gemcitabine for non-small cell lung cancer: Influence of scheduling on toxicity and drug delivery
6. Cisplatin-gemcitabine combination in advanced non-small cell lung cancer (NSCLC): A phase II study
7. Phase I/II study of gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer: Preliminary results
8. Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small cell lung cancer
9. A phase I study of gemcitabine and carboplatin in non-small cell lung cancer
10. Gemcitabine and carboplatin in combination: An update of phase I and phase II studies in non-small cell lung cancer
11. Gemcitabine and carboplatin in combination: Phase I and II studies
12. Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small cell lung cancer: A study of the Eastern Cooperative Oncology Group
13. Combination of gemcitabine (Gem) and carboplatin (Carbo) as first line treatment in non-small cell lung cancer (NSCLC)
14. Should all stage IV non-small cell lung cancer be treated palliatively?
15. Chemotherapy in stage IV (metastatic) non-small cell lung cancer
16. Chemotherapy of advanced non-small cell lung cancer
17. Future directions in non-small cell lung cancer: A continuing perspective
18. The use of gemcitabine in non-small cell lung cancer